Stay updated with breaking news from கொரோனா வைத்தியம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
We start with the much-anticipated deal between Indonesia’s two most valuable startups. Gojek and Tokopedia have sought approval from their respective shareholders to seal a merger deal after both companies’ boards gave the green light for the transaction. Once shareholder approval is obtained, the two companies will move to complete the transaction in a matter of weeks. A deal between super app Gojek, valued at $10.5 billion, and e-commerce unicorn Tokopedia, valued at $7.5 billion, would be by far the largest M&A deal ever to be seen in Indonesia’s tech sector. Another Indonesian unicorn, Bridgetown Holdings Ltd, a SPAC backed by billionaires ....
India: ChrysCapital to invest $50m for a significant minority stake in WOW Skin Science Photo: Pixabay April 8, 2021 Homegrown private equity firm ChrysCapital is investing $50 million for a significant minority stake in personal care brand WOW Skin Science India Limited. The transaction is a combination of a primary raise by the company for growth initiatives, and a secondary sale by existing shareholders, WOW said in a statement on Thursday. On partnering with ChrysCapital, Manish Chowdhary, co-founder of WOW, said, “The foundation of this relationship is our shared goal of creating sustainable value at WOW by creating a house of brands, accelerating growth, hiring talent, institutionalising the organisation, and expanding WOW’s presence in the beauty and personal care category. We also look forward to working closely with Enhancin, ChrysCapital’s portfolio operations group, to achieve these goals.” ....
ChrysCap to buy 30% in Corona Remedies for Rs 670 crore SECTIONS Share Synopsis ChrysCap has signed a deal to acquire 20% stake from PE firm Creador, which is an existing investor, and another 10% from promoters, two people aware of the development said. The announcement is due in a couple of days. Reuters Homegrown private equity fund ChrysCapital will invest about Rs 670 crore ($90 million) to acquire about 30% stake in Ahmedabad-based drug manufacturer Corona Remedies. ChrysCap has signed a deal to acquire 20% stake from PE firm Creador, which is an existing investor, and another 10% from promoters, two people aware of the development said. The announcement is due in a couple of days. ....
Indian PE firm ChrysCapital picks 27% stake in Corona Remedies Photographer: Krisztian Bocsi/Bloomberg April 5, 2021 Indian homegrown private equity (PE) major ChrysCapital has picked up a 27% stake in Gujarat-based drug manufacturer Corona Remedies through a secondary transaction, according to a press statement issued jointly by the companies on Monday. While other financial details of the transaction were not disclosed, DealStreetAsia had reported on March 30 that ChrysCapital is close to investing $100 million in Corona Remedies. The report also mentioned that Malaysian PE firm Creador is exiting as part of the transaction. Creador had acquired a 20% stake in Corona Remedies for Rs 120 crore in 2016. ....
Creador sets the ball rolling on its fifth fund Credor has clocked profitable returns from a bunch of exits in the last few years, including City Union Bank and Somany CeramicsPremium 2 min read Swet Sarika The PE firm is preparing to hit the market to raise a $600-700 mn fund and is likely to tap into its existing set of investors and may rope in some new institutions as LPs The proposed fund follows a $565 mn fourth fund, which has deployed over 3/4th of its corpus Share Via Read Full Story Creador, the South- and Southeast Asia-focused private equity firm founded by former ChrysCapital partner Brahmal Vasudevan, has set the ball rolling on its fifth fund after exhausting a large part of the corpus of its previous fund, two people aware of the development told VCCircle. ....